Moreover, targeting of metabolic enzymes, such as glucose transporters, hexokinase, PKM2, lactate dehydrogenase A, pyruvate dehydrogenase kinase, fatty acid synthase and glutaminase can enhance the efficacy of common therapeutic agents or overcome resistance to chemotherapy or radiotherapy for cancers[43,44]. Here, GLS is linked to cancer.